BioNTech
Europe, Rheinland-Pfalz, Germany, Mainz
Description
BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.
Investor Profile
BioNTech has made 5 investments, with 0 in the past 12 months and 40% as lead.
Stage Focus
- Series Unknown (40%)
- Post Ipo Equity (40%)
- Series B (20%)
Country Focus
- Germany (40%)
- United Kingdom (40%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Poland (20%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Alternative Protein
- Food And Beverage
- Organic Food
- Sustainability
- Artificial Intelligence (Ai)
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
